SCHEMBL10089926

SCHEMBL10089926

O=C(NCc1ccc(OC(F)(F)F)cc1)c1cc(Cl)cc(F)c1NC(=O)c1cc(Cn2nnc(C(F)(F)F)n2)nn1-c1ncccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.35
SCN5A Q14524 2/20 0.35
SCN9A Q15858 2/20 0.35
PTGER4 P35408 2/20 0.35
KLKB1 P03952 1/20 0.34
IDH1 O75874 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
LMNA P02545 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
GCGR P47871 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 2/20 0.33
RIPK1 Q13546 1/20 0.33
SCN2A Q99250 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10089951 0.94 ABCB1 (0.39) RIPK1
SCHEMBL10090018 0.94 IDH1 (0.36) KLKB1IDH1EGLN1LMNAHPGD
SCHEMBL10089898 0.93 PDE2A (0.35) KCNH2SCN5ASCN9APTGER4KLKB1
SCHEMBL10090033 0.93 PDE2A (0.35) KCNH2SCN5ASCN9APTGER4KLKB1
SCHEMBL10089836 0.90 PDE2A (0.35) PTGER4KLKB1EGLN1ALDH1A1HPGD
SCHEMBL10089880 0.90 PTGER4 (0.35) KCNH2SCN5ASCN9APTGER4KLKB1
SCHEMBL10089924 0.90 MMP13 (0.38) IDH1LMNAHPGD
SCHEMBL10089921 0.89 HSD17B13 (0.40) RIPK1EPHX2
SCHEMBL10090006 0.89 PTGER4 (0.37) PTGER4KLKB1IDH1EGLN1ALDH1A1
SCHEMBL17122545 0.88 MAPK8 (0.38) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582695-B1 ANTHRANILIC ACID DIAMIDE DERIVATIVES WITH CYCLICAL SIDE CHAINS BAYER IP GMBH (DE) 2015-09-30 EP disclosed
US-8791143-B2 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains DDT, ADCY1, ANTXR2 KCNH2 617/4885SCN5A 1232/4885SCN9A 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.